Please login to the form below

Not currently logged in
Email:
Password:

Perrigo appoints Gerresheimer’s Uwe Rohrhoff as CEO

He succeeds John Hendrickson, who resigns as CEO and board member

Generic pharmaceutical company Perrigo has appointed Uwe Rohrhoff, Gerresheimer’s former chief executive officer, as its new CEO.

Rohrhoff will succeed John Hendrickson, who resigns as both the Dublin-headquartered company's CEO and a member of its board.

The appointment has been one of a few changes at the company, just last year Perrigo’s chief financial officer Judy Brown stepped down from her role to join Amgen, and Ronald Winowiecki was appointed acting CFO.

Perrigo said that it suspended its search for a replacement CFO during its search for Hendrickson’s successor as CEO.

17th January 2018

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
OPEN Health

OPEN Health is a family of expert practices, working in partnership to drive positive change in healthcare communications & market...

Latest intelligence

BRIC markets
BRIC markets
Why these countries offer an opportunity for pharma despite a slowdown...
Obstetrics Virtual Journal Club: An Impetus Digital Customer Success Story
Our online solutions are not just for advisory boards - find out how one client leveraged the Impetus InSite Platform® for a virtual journal club....
Ludovic Helfgott
Novo Nordisk awakens its ‘Sleeping Beauty’
Biopharm emerges from troubled times to hit ‘solid growth’, says executive vice president Ludovic Helfgott...

Infographics